clinical trial · NCT06635148
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Janssen Research & Development, LLC·phase2·recruiting·n = 274
Geographic AtrophyMacular DegenerationJNJ-81201887Sham Procedure
brief summary
The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ-81201887 administered in parent clinical studies.
started
Sep 19, 2024
primary completion
Aug 24, 2029
completion
Jul 16, 2030
last updated
May 8, 2026
official title
Long-term Extension Study for Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol